RHGAP39, which stands for Rho GTPase Activating Protein 39, is a gene that encodes a protein belonging to the Rho GTPase-activating protein (GAP) family. Proteins in this family are involved in the regulation of Rho GTPases, a group of signaling molecules that play crucial roles in various cellular processes, including cell morphology, migration, cell cycle progression, and gene expression.Rho GTPases function as molecular switches within the cell, cycling between an active GTP-bound state and an inactive GDP-bound state. The role of ARHGAP39, like other GAPs, is to facilitate the inactivation of Rho GTPases by enhancing their intrinsic GTPase activity. This action converts the GTPases from their active form back to their inactive form, thereby regulating their signaling activities.
The specific biological functions and pathways in which ARHGAP39 is involved are not extensively detailed in general scientific literature. However, given the critical roles of Rho GTPases in cellular dynamics, ARHGAP39 likely plays a significant role in regulating cellular architecture, motility, and proliferation. It may be involved in processes such as cytoskeletal organization, cell adhesion, and the formation of cellular extensions like filopodia and lamellipodia.Alterations in the expression or function of ARHGAP39 could impact these cellular processes. Dysregulation of Rho GTPase activity has been implicated in a variety of diseases, including cancer, neurological disorders, and developmental abnormalities. Therefore, ARHGAP39 may have relevance in the context of these conditions, particularly where aberrant cell movement, growth, or differentiation are involved.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, impacting Rho kinase signaling pathways and potentially influencing ARHGAP39-related processes. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Statins, known for their cholesterol-lowering effects, also impact Rho GTPase signaling, potentially affecting ARHGAP39 activity. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
ML141 is a Cdc42 inhibitor, another member of the Rho GTPase family, potentially influencing ARHGAP39's regulatory role. | ||||||
PNU 120596 | 501925-31-1 | sc-203200 sc-203200A | 1 mg 5 mg | $32.00 $84.00 | 1 | |
Rhosin selectively inhibits RhoA activation, potentially modifying the cellular context in which ARHGAP39 operates. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin, another statin, also impacts Rho GTPase signaling and may indirectly influence ARHGAP39. | ||||||
Tozasertib | 639089-54-6 | sc-358750 sc-358750A | 25 mg 50 mg | $62.00 $87.00 | 4 | |
Tozasertib, a kinase inhibitor, might indirectly affect ARHGAP39 through its broad inhibitory effects on kinases involved in cell signaling. | ||||||
Fasudil, Monohydrochloride Salt | 105628-07-7 | sc-203418 sc-203418A sc-203418B sc-203418C sc-203418D sc-203418E sc-203418F | 10 mg 50 mg 250 mg 1 g 2 g 5 g 10 g | $18.00 $33.00 $87.00 $168.00 $253.00 $496.00 $910.00 | 5 | |
Fasudil, a Rho kinase inhibitor, can modulate Rho GTPase-mediated signaling pathways, potentially impacting ARHGAP39. | ||||||
GSK 269962 | 850664-21-0 | sc-363279 sc-363279A | 10 mg 50 mg | $300.00 $1000.00 | 1 | |
GSK269962A, a ROCK inhibitor, may influence Rho GTPase signaling pathways relevant to ARHGAP39's function. | ||||||
GSK 690693 | 937174-76-0 | sc-363280 sc-363280A | 10 mg 50 mg | $255.00 $1071.00 | 4 | |
TNP is a selective inhibitor of N-WASP, involved in actin dynamics and potentially interacting with pathways regulated by ARHGAP39. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
CK-666 inhibits Arp2/3 complex, which is involved in actin polymerization, potentially affecting ARHGAP39-mediated processes. | ||||||